← Open Payments lookup

PHILIP LOTTINGER: Open Payments

NPI 1013635937 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,224 in 57 payments from 14 companies in 2025. Trend: 2023 $707 · 2024 $984 · 2025 $1,224

Food & beverage: $1,224
CompanyPaymentsAmount
ABBVIE INC.13$239
Janssen Pharmaceuticals, Inc6$233
Neurocrine BioSciences, Inc.8$168
E.R. Squibb & Sons, L.L.C.9$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$113
Alkermes, Inc.4$76
Corium, LLC5$61
Merck Sharp & Dohme LLC2$43
Teva Pharmaceuticals USA, Inc.2$37
Otsuka America Pharmaceutical, Inc.2$33

Products named: VRAYLAR, SPRAVATO, INGREZZA, COBENFY, CAPLYTA, ARISTADA, Azstarys, PIFELTRO.

Industry payments across LA — which companies pay providers there.